Athyrium Opportunities Fund IV1
| Company | Description | Initial Investment Date |
|---|---|---|
| Aris Global | HCIT | July 2021 |
| Puma Biotechnology, Inc. | Biopharma / Nerlynx® | July 2021 |
| Aqua Dermatology | Dermatology Provider Group | October 2021 |
| RVL Pharmaceuticals plc | Biopharma / Upneeq® | October 2021 |
| Complete Health Partners, Inc. | Primary Care Staffing | October 2021 |
| TeamHealth | Physician Staffing Group | October 2021 |
| Team Services Group | Home Healthcare Services | October 2021 |
| Summit Behavioral Health | Behavioral Health | November 2021 |
| Oui Therapeutics, Inc. | Digital Therapeutics / Suicide Prevention | December 2021 |
| Vita Health | Digital Therapeutics / Suicide Prevention | December 2021 |
| BridgeBio Pharma Inc. | Biopharma / Nuliby® and Truseltiq® | December 2021 |
| Omeros Corporation | Small-Molecule and Protein Therapeutics | January 2022 |
| Revance Therapeutics, Inc. | Biopharma / Aesthetics | March 2022 |
| uMotif | eClinical Platform Provider | May 2022 |
| Paratek Pharmaceuticals | Biopharma / Nuzyra® | May 2022 |
| Heartland Veterinary Partners | Veterinary | July 2022 |
| Kindred Hospice | Home Hospice Care | August 2022 |
| Basilea | Biopharma / Anti-Infectives and Oncology | September 2022 |
| Unlock Health | Healthcare Digital Marketing | February 2023 |
| Calliditas Therapeutics | Biopharma / Tarpeyo® | December 2023 |
1. This table lists selected investments made by the Athyrium Opportunities Fund IV.